Replies to post #78754 on Amarantus Bioscience Holdings Inc (AMBS)

[Masala]

LymPro is junk, CEO hoodwinking investors, MANF development has stalled , exit exit

[zoomboom]

Also AMBS will file PreSubmission App to FDA for LymPro in 3rd Quarter 2013 was also noted in the original Chart they removed from the LymPro White Paper

they are just going through the formalities..its all working to plan. this will get green lighted and put in the express lane IMO... remember our government is focused on helping advance AD treatments and Early diagnostics is ultra important to that.

GL2ALL

[dshade]

This is a big buy opportunity and you point out the logic. Those with the vision and foresight to understand how this works will see .03, in the grand scheme of risk reward, as well worth the buy.

[Goldstrike]

Good points to ponder...